Microcystin Detection for Water Quality

High-Sensitivity Microcystin Detection and Quantification Services for Water Quality, Food Safety, and Environmental Monitoring

Microcystins are a class of potent hepatotoxins produced by cyanobacteria (blue-green algae) during harmful algal blooms (HABs) in freshwater and brackish water bodies. With over 240 known structural variants, microcystin-LR, -RR, and -YR are the most prevalent and toxic. These cyclic peptides inhibit protein phosphatases PP1 and PP2A, leading to liver damage, tumour promotion, and, in severe cases, fatal poisoning. Given their stability and resistance to conventional water treatment, the reliable and sensitive detection of microcystins is mandatory for drinking water safety, recreational water monitoring, aquaculture, and food safety (e.g., in fish, shellfish, and dietary supplements). Our specialized detection platform provides a fully validated suite of analytical methods—including ELISA, LC-MS/MS, and LC-HRMS—that deliver unparalleled sensitivity, specificity, and congener-specific resolution. Whether the client is a water utility, a regulatory agency, a food producer, or an environmental consultant, our service delivers the actionable, regulatory-compliant data needed to protect public health and ensure environmental stewardship.

Scientific and Regulatory Drivers for Microcystin Analysis

Clients seeking microcystin detection services are driven by multiple imperatives. In drinking water quality management, the World Health Organization (WHO) and national authorities (e.g., US EPA, EU) have established provisional guideline values for microcystin-LR (typically 1 µg/L), mandating routine monitoring. In recreational waters, rapid assessments are required to issue health advisories. In aquaculture and fisheries, microcystin accumulation in fish and shellfish poses a food safety risk, requiring monitoring of both water and edible tissues. In dietary supplement manufacturing, products containing cyanobacteria (e.g., Spirulina) must be screened to ensure they are free from microcystin contamination. Furthermore, in environmental research, understanding the occurrence and dynamics of microcystins supports bloom prediction and mitigation strategies. Our service is architected to address these needs with a flexible, multi-tiered approach that adapts to the client's specific matrix and regulatory framework.

Integrated Analytical Pipeline for Comprehensive Microcystin Profiling

Our analytical platform is organized into three interconnected modules that collectively deliver high-confidence data for microcystin analysis. The Initial Screening Module utilizes competitive ELISA (enzyme-linked immunosorbent assay) based on monoclonal antibodies raised against microcystin-LR, which cross-react with several major congeners. This method provides semi-quantitative results within 2–3 hours with a limit of detection (LOD) of 0.1 µg/L in water and 0.5 µg/kg in solid matrices (e.g., algal bloom material, fish tissue). The ELISA serves as a cost-effective screening tool for high sample numbers, enabling rapid identification of samples requiring confirmatory analysis. The Confirmatory and Quantitative Module employs ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) in multiple reaction monitoring (MRM) mode, targeting the most common congeners (LR, RR, YR, LA, LY, LW, and LF). We use isotopically labeled internal standards (e.g., microcystin-LR-¹⁵N₅) to correct for matrix effects and extraction losses, achieving LODs as low as 0.01 µg/L in water and 0.05 µg/kg in solid matrices, with inter-day precision (RSD) < 5% and accuracy of 95–105%. The method includes an effective solid-phase extraction (SPE) cleanup using C18 or polymer-based sorbents to remove interfering co-extracted compounds. For structural elucidation and discovery of novel or uncommon microcystin variants, we apply high-resolution mass spectrometry (HRMS) on a Q-TOF or Orbitrap instrument, providing full-scan and data-dependent MS/MS with mass accuracy < 2 ppm and enabling the identification of congeners not covered by standard MRM panels. Additionally, we offer hydrolysis of protein-bound microcystins in tissue samples to release total bound toxins, using oxidative (e.g., performic acid) or enzymatic methods, followed by LC-MS/MS analysis. All modules are validated according to EPA Method 544, ISO 20179, and AOAC guidelines, and we provide full validation dossiers including specificity, linearity, recovery, and robustness.

Unmatched Sensitivity, Specificity, and Structural Coverage

Our platform consistently delivers performance that exceeds regulatory requirements. In confirmatory analysis, our LC-MS/MS method resolves all targeted congeners with baseline chromatographic separation (R_s > 2.0) within a 12-minute gradient. The use of internal standards ensures recoveries of 90–110% across a wide concentration range (0.01–100 µg/L), with method detection limits (MDLs) in the low ng/L range for water. For complex matrices like algal scum or fish tissue, our sample preparation includes pressurized liquid extraction or QuEChERS with matrix-matched calibration to eliminate ion suppression. In HRMS, our spectral library includes >50 known microcystins and their fragmentation patterns, allowing confident identification of unusual peaks. We also perform quantification of total microcystins via an MMPB (2-methyl-3-methoxy-4-phenylbutyric acid) method (i.e., Lemieux oxidation) followed by LC-MS/MS, providing a single readout of the total microcystin burden regardless of congener composition. This multi-pronged approach ensures that clients receive both congener-specific and total toxicity-equivalent data, enabling them to make informed risk management decisions.

Distinctive Advantages of Our Microcystin Detection Service

Our service provides several unique benefits that directly address client challenges. First, we offer customized extraction and cleanup protocols for a broad spectrum of matrices—including raw and finished drinking water, surface water, wastewater, cyanobacterial bloom material, fish muscle, shellfish, plant-based dietary supplements, and even serum or urine for biomonitoring studies—with validated recoveries for each type. Second, we maintain an extensive in-house reference standard library containing over 25 microcystin congeners and several nodularins, enabling accurate quantification and confirmation. Third, we provide a rapid on-site screening option using a portable ELISA kit with a handheld photometric reader, delivering results within 20 minutes of sampling—ideal for field campaigns and emergency response. Fourth, our stability studies evaluate the degradation of microcystins under various storage conditions (temperature, pH, light), helping clients to optimize sample handling and storage protocols. Fifth, we offer integrated data interpretation that includes conversion of congener concentrations to toxic equivalent quantities (TEQs) based on relative toxicity factors, facilitating direct comparison with guideline values. Sixth, all our methods are accredited under ISO/IEC 17025 and comply with EPA and EU Water Framework Directive requirements; we provide full validation reports and are regularly audited by external proficiency testing providers (e.g., ERA, FAPAS). Our team of environmental chemists and toxicologists provides consultative support, helping clients to design monitoring programmes, interpret complex data, and implement corrective actions when exceedances occur.

Advanced Data Integration, Trend Analysis, and Reporting

Our reporting goes beyond simple concentration values to deliver actionable intelligence. We provide a comprehensive report that includes: (i) an executive summary with a clear pass/fail judgement against the relevant guideline (e.g., WHO, US EPA, EU); (ii) a detailed analytical section with chromatograms, mass spectra, calibration curves, and quality control data; (iii) a statistical summary for multiple samples, with means, standard deviations, and confidence intervals; and (iv) an interpretive section that discusses the implications of the results—for example, identifying the dominant congener, the likely source of contamination, or the seasonal pattern of occurrence. For clients with ongoing monitoring programmes, we provide time-series plots and control charts to detect trends and alert to emerging risks. We also offer spatial mapping of results when sample locations are provided, aiding in the identification of contamination hotspots. All raw data (e.g., .raw, .cdf, .csv) are supplied for client verification and further analysis.

Broad Applications Across Water Utilities, Public Health, and Food Safety

The versatility of our microcystin detection service makes it indispensable across multiple sectors. In drinking water treatment plants, our monitoring supports the optimization of treatment processes (coagulation, filtration, activated carbon) and ensures regulatory compliance. In recreational water management, our rapid screening allows for timely beach closures and health warnings. In aquaculture and fishery industries, our tissue testing validates the safety of seafood products for human consumption. In dietary supplement companies, our screening guarantees that products derived from cyanobacteria meet purity specifications. In environmental research and consulting, our comprehensive profiling informs bloom dynamics studies and risk assessments. In clinical and public health laboratories, our biomonitoring methods support epidemiological investigations. Our ability to adapt our approach to the specific regulatory context and end-user needs ensures that we serve clients at all levels—from small municipalities to multinational corporations.

Commitment to Innovation, Quality, and Client Partnership

We are dedicated to maintaining leadership in cyanotoxin analysis through continuous R&D. Our current work includes the development of antibody-based biosensors for near-real-time, low-cost field monitoring, and the application of machine learning algorithms to predict microcystin occurrence from routine water quality parameters. We actively participate in standardization committees and collaborate with regulatory bodies to update official methods. Our quality management system is ISO 9001 and ISO 17025 certified, and we follow GLP guidelines. We offer flexible service agreements—from single-shot sample analysis to multi-year monitoring programmes with dedicated project managers, volume discounts, and priority handling for emergency samples. Our global logistics network provides specialized shipping containers (amber glass, with preservatives such as sodium thiosulfate) and detailed instructions to ensure sample stability during transit. Turnaround times are typically 2 business days for ELISA screening and 5 business days for confirmatory LC-MS/MS, with expedited options available for urgent cases. We maintain open and transparent communication, providing interim reports and expert advice as needed. Our success is measured by our clients' ability to protect public health and comply with regulations confidently. We invite you to partner with us for rigorous, reliable, and insightful microcystin detection services.

In summary, our microcystin detection service delivers a comprehensive, precise, and regulatory-ready analytical solution that integrates rapid screening, confirmatory quantitation, congener-specific and total analysis, and expert interpretation. By combining state-of-the-art instrumentation with deep expertise in aquatic toxicology and analytical chemistry, we empower our clients to safeguard water resources, ensure food safety, and advance environmental research. We look forward to supporting your microcystin analysis needs with our unwavering commitment to quality and scientific integrity.